CD8+, radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease

Clinical Immunology and Immunopathology

Volumn 89, Issue 3, 1998, Pages 260-270

  Mann, Richard A ^a   Schiff, Devora ^a   Jetzt, Amanda E ^a   Ron, Yacov ^a   Singh, Manjeet ^a   Singh, Ajay B ^a  

^a Department of Emergency Medicine   (United States)

Author keywords

Cytotoxicity; Graft versus host disease; Tolerance suppression

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; DRUG CYTOTOXICITY; GRAFT VERSUS HOST REACTION; IMMUNOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

EID: 0032387824     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4611     Document Type: Article

References (40)

1. Gleichmann E. S., Pals S. T., Rolink A. G., Radaszkiewicz T., Gleichmann H. Graft-versus-host reactions: Clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today. 5:1984;324-332.
2. Via C. S., Sharrow S. O., Shearer G. M. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139:1987;1840-1849.
3. Bruijn J. A., Bergijk E. C., DeHeer E., Fleuren G. J., Hoedemaeker P. J. Induction and progression of experimental lupus nephritis: Exploration of a pathogenetic pathway. Kidney Int. 41:1992;5-13.
4. Singh A. B., Hiehle K., Singh M., Jetzt A. E., O'Connell S. M., Mann R. A. The host response in graft versus host disease. I. Radiosensitive T cells of host origin inhibit parental anti-F1 cytotoxicity in murine chronic graft versus host disease. Cell. Immunol. 151:1993;24-38.
5. Mann R. A., Singh A. B., Singh M., Jetzt A. E. The host response in graft versus host disease. II. The emergence of host protective cells is in part determined by background genomic compatibility. Cell. Immunol. 151:1993;39-51.
6. Mann R. A., Singh A. B., Jetzt A., Singh M. The host response in graft versus host disease. III. Thein vitro. Cell. Immunol. 164:1995;1-10.
7. Bruce J., Symington F. W., McKearn T. J., Sprent J. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127:1981;2496-2501.
8. Sarmiento M., Glasebrook A. L., Fitch F. W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:1980;2665-2672.
9. Dialynas D. P., Wilde D. B., Marrack P., Pierres A., Wall K. A., Havron W., Otten G., Loken M. R., Pierres M., Kappler J. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:1983;29-56.
10. Fink P. J., Shimonkevitz R. P., Bevan M. J. Veto cells. Ann. Rev. Immunol. 6:1988;115-137.
11. Tscherning T., Claesson M. H. Veto suppression: The peripheral way of T cell tolerization. Exp. Clin. Immunogen. 10:1993;179-188.
12. Thomas J. M., Verbanac K. M., Carver F. M., Kasten-Jolly J., Haisch C. E., Gross U., Smith J. P. Veto cells in transplantation tolerance. Clin. Transplant. 9:1994;195-203.
13. Sambhara S. R., Miller R. G. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science. 252:1991;1424-1427.
14. +in vivo. J. Immunol. 148:1992;3740-3745.
15. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263-266.
16. Mosmann T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol. Today. 17:1996;138-146.
17. Kroemer G., Hirsch F., Gonzalez-Garcia A., Martinez C. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity. 24:1996;25-33.
18. Charlton B., Lafferty K. J. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7:1995;793-798.
19. Nicholson L. B., Kuchroo V. K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:1996;837-842.
20. Adorini L., Guery J. C., Trembleau S. Manipulation of the Th1/Th2 cell balance: An approach to treat human autoimmune diseases. Autoimmunity. 23:1996;53-68.
21. Krenger W., Ferrara J. L. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15:1996;50-73.
22. DeWit D., Van Mechelen M., Zanin C., Doutrelepont J. M., Velu T., Gerard C., Abramowicz D., Scheerlinck J., DeBaetselier P., Urbain J., Leo O., Goldman M., Moser M. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150:1993;361-366.
23. Garlisi C. G., Pennline K. J., Smith S. R., Siegal M. I., Umland S. P. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol. Immunol. 30:1993;669-677.
24. Allen R. D., Staley T. A., Sidman C. L. Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur. J. Immunol. 23:1993;333-337.
25. Via C. S., Finkelman F. D. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5:1993;565-572.
26. Rus V., Svetic A., Nguyen P., Gause W. C., Via C. S. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J. Immunol. 155:1995;2396-2406.
27. +. Immunol. Today. 15:1994;107-110.
28. +in vivo. Immunology. 80:1993;326-329.
29. Renz H., Lack G., Saloga J., Schwinzer R., Bradley K., Loader J., Kupfer A., Larsen G. L., Gelfand E. W. Inhibition of IgE production and normalization of airway responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J. Immunol. 152:1994;351-360.
30. +. Scand. J. Immunol. 36:1992;769-777.
31. Oriss T. B., McCarthy S. A., Morel B. F., Campana M. A., Morel P. A. Crossregulation between T helper cells (Th)1 and Th2: Inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J. Immunol. 158:1997;3666-3672.
32. Szebeni J., Wang M. G., Pearson D. A., Szot G. L., Sykes M. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host disease. Transplantation. 58:1994;1385-1393.
33. +. Transplantation. 60:1995;481-490.
34. Huchet R., Bruley-Rosset M., Mathiot C., Grandjon D., Halle-Pannenko O. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression. J. Immunol. 150:1993;2517-2524.
35. Seder R. A. The role of IL-12 in the regulation of Th1 and Th2 differentiation. Res. Immunol. 146:1995;473-476.
36. Lamont A. G., Adorini L. IL-12: A key cytokine in immune regulation. Immunol. Today. 17:1996;214-217.
37. Perez V. L., Lederer J. A., Carniel E., Lichtman A., Abbas A. K. The role of IL-12 in helper T-cell differentiation. Res. Immunol. 146:1995;477-480.
38. Trinchieri G. Function and clinical use of interleukin-12. Curr. Opin. Hematol. 4:1997;59-66.
39. Via C. S., Rus V., Gately M. K., Finkelman F. D. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic autoimmune graft-versus-host disease. J. Immunol. 153:1994;4040-4047.
40. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1997;1541-1550.